Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Improvements in No Evidence of Disease Activity with Ublituximab Vs. Teriflunomide in the ULTIMATE Phase 3 Studies in Relapsing Multiple Sclerosis

Enrique Alvarez,Lawrence Steinman,Edward J. Fox,Hans-Peter Hartung,Peiqing Qian,Sibyl Wray,Derrick Robertson,Krzysztof Selmaj,Daniel Wynn,Koby Mok,Yihuan Xu,Karthik Bodhinathan,Hari P. Miskin,Bruce A. C. Cree

FRONTIERS IN NEUROLOGY（2024）

Cited 0|Views2
Key words
anti-CD20,disability,disease activity,disease-modifying therapy,multiple sclerosis,no evidence of disease activity,relapse,BRIUMVI
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined